Thrombectomy for Acute Stroke Due to Medium Vessel Occlusion Across Perfusion Mismatch Profiles: A Post Hoc - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Thrombectomy for Acute Stroke From Medium Vessel Occlusion Across Perfusion Mismatch Patterns: A Post Hoc Analysis

  • By

  • Umberto Pensato

  • Gunjan Jindal

  • William Diprose

  • Aravind Ganesh

  • Pattarawut Charatpangoon

  • Ethan MacDonald

  • Alexander Stebner

  • Salome Bosshart

  • Dar Dowlatshahi

  • David Volders

  • James Kennedy

  • Markus Möhlenbruch

  • Brian H. Buck

  • Shahid Nimjee

  • Thomas Booth

  • Mouhammad Jumaa

  • Jai J. Shankar

  • Franziska Dorn

  • Andrew M. Demchuk

  • Mayank Goyal

  • Michael D. Hill

  • Johanna M. Ospel

  • ESCAPE-MEVO Investigators

  • Jennifer Mandzia

  • Sachin Pandey

  • Jesse Klostranec

  • Lissa Peeling

  • Joanna Schaafsma

  • Timo Krings

  • Atif Zafar

  • Ravinder-Jeet Singh

  • Demetrios Sahlas

  • Thalia Field

  • Richard Swartz

  • Pual (Inder) Singh

  • Koji Ebersole

  • Negar Asdashi

  • Dileep Yavagal

  • Reade De Leacy

  • George Lopez

  • Babak Jahromi

  • Ronald Budzik

  • Seon-Kyu Lee

  • Eric Sauvageau

  • Adewumi Amole

  • Maxim Mokin

  • Mchael Levitt

  • Jason Tarpley

  • Albert Yoo

  • Michael Chen

  • Thanhn Nguyen

  • Santiago Ortega-Gutierrez

  • Adnan Siddiqui

  • Fabio Settecase

  • Thien Huynh

  • Tufail Patankar

  • Levansri Makalanda

  • Paul Burns

  • Changez Jadun

  • Aubrey Smith

  • Kyriakos Lobotesis

  • Rob Crossley

  • Robert Lenthall

  • Thant Hlaing

  • Ayokunle Ogungbemi

  • Liqun Zhang

  • Richard Marigold

  • Yogish Joshi

  • Richard Perry

  • Christian Hametner

  • Sven Poli

  • Joerg Berrouschot

  • Christian Taschner

  • Arno Reich

  • Hauke Scheider

  • Sandor Nardai

  • Gabor Lenzser

  • October 13, 2026

Share

  • 1

    Three randomized trials found no advantage of endovascular thrombectomy over medical therapy for medium vessel occlusion stroke.

  • 2

    This post hoc analysis used ESCAPE-MeVO trial data to examine whether perfusion mismatch profiles were associated with outcomes or modified the effect of thrombectomy.

  • 3

    The analysis included trial participants with interpretable baseline perfusion imaging and an available 90-day modified Rankin Scale score.

  • 4

    Perfusion mismatch volume was calculated as the difference between tissue with Tmax greater than 6 seconds and ischemic core with relative cerebral blood flow below 30%.

  • 5

    The primary outcome was the ordinal 90-day modified Rankin Scale score; secondary outcomes included 90-day functional status and 24-hour infarct volume.

Original Source(s)

Related Content